Prothena Corp Public (PRTA) Return on Sales (2012 - 2026)

Prothena Corp Public's Return on Sales history runs 15 years deep, the most recent figure standing at 0.01% for Q1 2026.

• On a quarterly basis, Return on Sales rose 22.0% year-over-year to 0.01% in Q1 2026; TTM through Mar 2026 was 0.03%, a 2.0% decrease from a year earlier, with the FY2025 full-year figure at 0.25%, down 24.0% from the prior year.
• Return on Sales grew to 0.01% in Q1 2026 per PRTA's latest filing, from 10.26% in the prior quarter.
• Across five years, Return on Sales topped out at 0.01% in Q1 2026 and bottomed at 14.45% in Q1 2024.
• The 5-year median for Return on Sales is 0.27% (2024), against an average of 1.74%.
• Across the five-year window, Return on Sales plunged 1423 bps in 2024 and surged 1423 bps in 2025, its largest moves.
• Year by year, Return on Sales stood at 0.0% in 2022, then sank by 168003 bps to 2.14% in 2023, then soared by 87 bps to 0.27% in 2024, then tumbled by 3656 bps to 10.26% in 2025, then soared by 100 bps to 0.01% in 2026.
• Per Business Quant, the three latest PRTA Return on Sales figures stand at 0.01% (Q1 2026), 10.26% (Q4 2025), and 0.15% (Q3 2025).